SCHEMBL4417707

SCHEMBL4417707

COc1ccc(C(C)(C)C)cc1C(=O)Nc1ccc(C)c(-c2cc(CNC(=O)c3cccnc3)on2)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.43
CYP1A2 P05177 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
TSHR P16473 1/20 0.43
BLM P54132 1/20 0.43
GAA P10253 2/20 0.43
CYP2C19 P33261 2/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
RAB9A P51151 2/20 0.42
BRAF P15056 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPT P10636 2/20 0.41
NAMPT P43490 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 1/20 0.40
FLT3 P36888 1/20 0.40
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4407836 0.92 NR1H4 (0.45) KMT2ABRAFMAPTHTTKDM4E
SCHEMBL4414236 0.92 NAMPT (0.43) CYP3A4CYP1A2TSHRCYP2C19L3MBTL1
SCHEMBL5593328 0.88 RXFP1 (0.43) MEN1KMT2ATSHRBRAFMAPT
SCHEMBL5592971 0.86 RXFP1 (0.42) CYP1A2MEN1KMT2ATSHRBRAF
SCHEMBL4419761 0.86 CYP1A2 (0.49) CYP3A4CYP1A2MEN1KMT2ATSHR
SCHEMBL4551631 0.86 GRM4 (0.49) RAB9ASMN1; SMN2KDM4EALDH1A1FLT3
SCHEMBL5616375 0.85 MAPT (0.48) MEN1KMT2ATSHRBLMGAA
SCHEMBL5592986 0.85 RXFP1 (0.41) MEN1KMT2ATSHRBRAFSMN1; SMN2
SCHEMBL4407658 0.82 NPC1 (0.42) CYP3A4CYP1A2MEN1KMT2ATSHR
SCHEMBL5604346 0.80 HTT (0.42) CYP3A4CYP1A2MEN1KMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed